SPS
Susquehanna Portfolio Strategies Portfolio holdings
AUM
$4.58B
This Quarter Return
+15.57%
1 Year Return
+20.83%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$5.62B
AUM Growth
–
Cap. Flow
+$5.62B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
10.58%
Holding
992
New
992
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Kenvue
KVUE
|
$145M |
| 2 |
Meta Platforms (Facebook)
META
|
$70.6M |
| 3 |
JPMorgan Chase
JPM
|
$51.8M |
| 4 |
Lowe's Companies
LOW
|
$49.8M |
| 5 |
Morgan Stanley
MS
|
$47.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 16.64% |
| 2 | Healthcare | 15% |
| 3 | Technology | 13.56% |
| 4 | Industrials | 13.2% |
| 5 | Consumer Discretionary | 12.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAGN
976
Magnera Corporation
MAGN
$441M
| $98.5K | ﹤0.01% |
+50,793
| New | +$98.5K |
|
|
DDL
977
Dingdong
DDL
$447M
| $96.6K | ﹤0.01% |
+64,405
| New | +$96.6K |
|
978
NGL Energy Partners
NGL
$692M
| $94.7K | ﹤0.01% |
+17,003
| New | +$94.7K |
|
979
8x8 Inc
EGHT
$270M
| $89.3K | ﹤0.01% |
+23,629
| New | +$89.3K |
|
980
Acumen Pharmaceuticals
ABOS
$82.4M
| $84.1K | ﹤0.01% |
+21,903
| New | +$84.1K |
|
981
Applied Therapeutics
APLT
$71M
| $84.1K | ﹤0.01% |
+25,095
| New | +$84.1K |
|
|
CONN
982
DELISTED
Conn's Inc.
CONN
| $84K | ﹤0.01% |
+18,930
| New | +$84K |
|
983
Fortuna Silver Mines
FSM
$2.36B
| $83.4K | ﹤0.01% |
+21,600
| New | +$83.4K |
|
984
Porch Group
PRCH
$1.77B
| $66.4K | ﹤0.01% |
+21,560
| New | +$66.4K |
|
985
Vimeo
VMEO
$696M
| $64.1K | ﹤0.01% |
+16,350
| New | +$64.1K |
|
986
ImmunityBio
IBRX
$2.21B
| $52.2K | ﹤0.01% |
+10,392
| New | +$52.2K |
|
987
CytomX Therapeutics
CTMX
$336M
| $49.4K | ﹤0.01% |
+31,869
| New | +$49.4K |
|
|
TE
988
T1 Energy Inc.
TE
$257M
| $46.6K | ﹤0.01% |
+24,900
| New | +$46.6K |
|
989
BioAtla
BCAB
$26.7M
| $46K | ﹤0.01% |
+18,691
| New | +$46K |
|
|
THRX
990
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $45K | ﹤0.01% |
+11,112
| New | +$45K |
|
|
TVRD
991
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $42.4K | ﹤0.01% |
+57,071
| New | +$42.4K |
|
992
BigBear.ai
BBAI
$1.88B
| $31.8K | ﹤0.01% |
+14,850
| New | +$31.8K |
|